Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy
Ziyang Zhang, Peter J. Rohweder, Chayanid Ongpipattanakul, et al.
Cancer Cell (2022) Vol. 40, Iss. 9, pp. 1060-1069.e7
Open Access | Times Cited: 91

Showing 26-50 of 91 citing articles:

Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Alchemical Transformations and Beyond: Recent Advances and Real-World Applications of Free Energy Calculations in Drug Discovery
Runtong Qian, Jing Xue, You Xu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 19, pp. 7214-7237
Closed Access | Times Cited: 5
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy
Laura D'Alessio‐Sands, Joshua Gaynier, Victoria Michel‐Milian, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Recombinant Antibodies Inhibit Enzymatic Activity of the E3 Ubiquitin Ligase CHIP via Multiple Mechanisms
Dong hee Chung, Emily J. Connelly, Aparna Unnikrishnan, et al.
Journal of Biological Chemistry (2025), pp. 108220-108220
Open Access
First molecules to reactivate RASG12V GTPase activity
Aneta Włodarczyk, Cezary Tręda, Marcin Pacholczyk, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Electrically Driven, Bioluminescent Compliant Devices for Soft Robotics
Kengo Kusama, Atsuro Oishi, Hitoshi Ueno, et al.
ACS Applied Materials & Interfaces (2025)
Open Access
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
Targeting STAT3 for Cancer Therapy: Focusing on Y705, S727, or Dual Inhibition?
Kyli Berkley, Julian Zalejski, Ashutosh Sharma
Cancers (2025) Vol. 17, Iss. 5, pp. 755-755
Open Access
Allostery in Disease: Anticancer Drugs, Pockets, and the Tumor Heterogeneity Challenge
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Journal of Molecular Biology (2025), pp. 169050-169050
Open Access
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Adith S. Arun, David Liarakos, Gaurav Mendiratta, et al.
PubMed (2025) Vol. 25, Iss. 1-2, pp. 5-5
Closed Access
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer
Krishnan K. Mahadevan, Antonio Maldonado, Bingrui Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
Antigen discovery for the development of cancer immunotherapy
Ryuhjin Ahn, Yufei Cui, Forest M. White
Seminars in Immunology (2023) Vol. 66, pp. 101733-101733
Open Access | Times Cited: 12
Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance
Ruth Nussinov, Hyunbum Jang
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 231-253
Closed Access | Times Cited: 12
Targeting KRAS in pancreatic cancer: Emerging therapeutic strategies
Sajid Khan, Vivekananda Budamagunta, Daohong Zhou
Advances in cancer research (2023), pp. 145-184
Closed Access | Times Cited: 11
Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors
Xile Zhou, Yang Ji, Jinming Zhou
Molecules (2023) Vol. 28, Iss. 8, pp. 3615-3615
Open Access | Times Cited: 11
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
Yi Zhou, Yaxin Zhang, Mingzhou Li, et al.
Science Immunology (2024) Vol. 9, Iss. 100
Closed Access | Times Cited: 4
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets
Kilian Colas, Daniel Bindl, Hiroaki Suga
Chemical Reviews (2024) Vol. 124, Iss. 21, pp. 12213-12241
Open Access | Times Cited: 4
Immunotherapy in gastrointestinal cancers: advances, challenges, and countermeasures
Zixian Wang, Yi‐Qian Pan, Xuexin Li, et al.
Science Bulletin (2023) Vol. 68, Iss. 8, pp. 763-766
Open Access | Times Cited: 10
Immune vulnerabilities of mutant KRAS in pancreatic cancer
Noah Cheng, Robert H. Vonderheide
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 928-936
Open Access | Times Cited: 10
Defining the Cell Surface Cysteinome Using Two-Step Enrichment Proteomics
Tianyang Yan, Lisa M. Boatner, Liujuan Cui, et al.
JACS Au (2023) Vol. 3, Iss. 12, pp. 3506-3523
Open Access | Times Cited: 9
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS mutations
Gerald P. Linette, Adham S. Bear, Beatriz M. Carreno
Clinical Cancer Research (2024) Vol. 30, Iss. 10, pp. 2017-2024
Open Access | Times Cited: 3
Energy Metabolism as a Therapeutic Target in Cancer: The Role of Coenzyme Q10
David Mantle, Hannah Rowbottom, Jacob L. Jones, et al.
Oxygen (2024) Vol. 4, Iss. 2, pp. 122-138
Open Access | Times Cited: 3

Scroll to top